This is all quite confusing. On the one hand we have the cult putting up death rates for Covid-19 and lamenting no one is approving anything to save their soles.
On the other hand we had Novartis who was in a partnership with msb (subject to closing conditions including reviewing the trial data) who, after reviewing the trial data, pulled out of the partnership.
It would seem to me to be inconceivable that Novartis would pull out of a product which touted as a miracle cure in the biggest health crisis the world has seen in a hundred years.
then, we have the FDA giving approvals for just about anything that might help in this Covid crisis. A pretty low bar. But, not for stems. Nope. Far from it. Nope. MSB must fix their quality control problems and, then, do further trials. Two year wait at best.
Why would all this be the case. Well, let’s unconfuse things. Stems are not the miracle cure and don’t work as advertised. Simple as that.
Maybe this is akin to the famous stem cell chicken heart scandal?
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-95
-
- There are more pages in this discussion • 811 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |